Corporate and Operational Architecture
The Ginkgo biloba Industrial Development Program operates within a structured multi-entity framework designed to separate strategic research direction, agricultural execution and long-term asset governance.
The project is not a standalone agricultural initiative.
It is a coordinated development program integrated within a broader industrial structure.
Strategic Origin and Direction
TEHNOFARM S.R.L.
Founded in 1992, TEHNOFARM S.R.L. defines the long-term botanical-pharmaceutical orientation of the project.
Responsibilities include:
- research direction and conceptual development
- definition of genetic selection criteria
- industrial roadmap planning
- laboratory validation strategy (2026 phase)
- integration with pharmaceutical-oriented platforms
The Ginkgo program originates from strategic planning within TEHNOFARM.
Agricultural Execution
NORD NUC S.R.L.
Established in 2021 as a dedicated agricultural operator.
Responsibilities include:
- field plantation establishment (0.3 ha pilot, 17 September 2021)
- nursery selection (5,000 plants)
- structural screening and exclusion cycles
- winter validation under open-field exposure
- preparation of elite candidates for In Vitro phase
- operational preparation for Alpine deployment
NORD NUC S.R.L. is the biological execution unit of the program.
Corporate Governance
TF HOLDING S.R.L.
Provides:
- ownership structure
- capital coordination
- strategic alignment across development platforms
- long-term asset consolidation
The holding structure ensures continuity across decades of phased development.
Multi-Platform Integration
The Ginkgo ecosystem operates across distinct but coordinated platforms:
Biological Development & Field Validation
https://ginkgo.md
Pharmaceutical-Oriented Framework
https://ginkgo-pharma.com
Alpine Deployment & European Industrial Strategy
https://ginkgo-pharma.eu
Botanical Research Documentation
https://ginkgo-biloba.eu
Each platform serves a defined functional role within the overall industrial architecture.
Project Timeline within Corporate Structure
1992 — Strategic botanical direction initiated (TEHNOFARM S.R.L.)
2009 — Controlled cultivation model defined
2011–2016 — Research architecture structured
2021 — NORD NUC S.R.L. established for field execution
2026 — Laboratory analytical validation
2027 — In Vitro clonal stabilisation
2029 — Alpine industrial deployment
2033 — First industrial harvest
The structure is designed for multi-decade continuity rather than short-term production cycles.